ABO-incompatible living donor liver transplantation: new insights into clinical relevance.
Short-term outcome of the ABO-incompatible liver transplantation has been improved dramatically due to novel immnosuppressive protocols and apheresis. This review will discuss current understanding of the clinical relevance of ABO-incompatible liver transplantation including long-term outcome mainly from the Japanese experience.
Kawagishi
Naoki
N
Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, Sendai, Japan. kawan@mail.tains.tohoku.ac.jp
Satomi
Susumu
S
D000017:ABO Blood-Group System; D001781:Blood Component Removal / Q000379:methods*; D001787:Blood Group Incompatibility / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation; D019520:Living Donors; D011300:Preoperative Care; D011379:Prognosis
D000017:ABO Blood-Group System